FindTrial
Sign In

Impact of COVID-19 pandemic on status epilepticus: changes in etiology spectrum, clinical features and prognosis

Impact of COVID-19 pandemic on status epilepticus: changes in etiology spectrum, clinical features and prognosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600118170
Enrollment
Unknown
Registered
2026-02-03
Start date
2026-02-15
Completion date
Unknown
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Status epilepticus

Interventions

Pre-COVID(group 1):None
Post-COVID(group 2):None

Sponsors

Chinese Academy of Medical Sciences, Peking Union Medical College Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Age: 14 to 80 years old; 2.Patients hospitalized at Peking Union Medical College Hospital or Cangzhou Central Hospital between 2010 and 2025 who experienced seizures meeting diagnostic criteria for status epilepticus during admission or hospitalization.

Exclusion criteria

Exclusion criteria: 1.Pregnant or breastfeeding women; 2.Patients with severely incomplete medical records who cannot undergo effective evaluation;

Design outcomes

Primary

MeasureTime frame
Modified Rankin Scale (mRS) score;Electroencephalogram (EEG) findings;Clinical seizure status;Glasgow Outcome Scale Extended (GOSE) score;—

Countries

China

Contacts

Public ContactQing Liu

Chinese Academy of Medical Sciences, Peking Union Medical College Hospital

drliuqing@126.com+86 10 69156371

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026